Supernus Pharmaceuticals (SUPN) Other Working Capital Changes (2011 - 2026)

Supernus Pharmaceuticals (SUPN) has 10 years of Other Working Capital Changes data on file, last reported at -$758000.0 in Q3 2020.

• On a quarterly basis, Other Working Capital Changes rose 33.97% year-over-year to -$758000.0 in Q3 2020; TTM through Sep 2020 was -$6.1 million, a 425.9% decrease from a year earlier, with the FY2019 full-year figure at -$5.1 million, down 712.27% from the prior year.
• Other Working Capital Changes for Q3 2020 stood at -$758000.0, up from -$1.0 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for SUPN reached as high as $28.2 million in Q2 2023 and fell as low as -$20.4 million in Q3 2023.
• Historically, Other Working Capital Changes has averaged $1.9 million across 5 years, with a median of $341000.0 in 2023.
• Across the five-year window, Other Working Capital Changes jumped 2996.39% in 2017 and sank 529.82% in 2019, its largest moves.
• Year by year, Other Working Capital Changes stood at -$194000.0 in 2016, then soared by 2996.39% to $5.6 million in 2017, then tumbled by 86.81% to $741000.0 in 2018, then sank by 529.82% to -$3.2 million in 2019, then jumped by 76.2% to -$758000.0 in 2020.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$758000.0 in Q3 2020, -$1.0 million in Q1 2020, and -$3.2 million in Q4 2019.